Osteogenesis Imperfecta Type 3 — Clinical Trials

MONDO:00098041 activeLast updated: Mar 19, 2026, 11:04 PM

Osteogenesis Imperfecta Type 3 has an emerging clinical trial program, driven by drug treatment.

Recruiting

Active Trials

Drug Treatment1

Phase 1

Phase 2

Academic/Other1

1 Trial

Phase 1Not Yet Recruiting

Started: Feb 2026Est. completion: Oct 2026Updated: Oct 2025

Stay informed about clinical trials for Osteogenesis Imperfecta Type 3.

Follow this disease to get updates when trials open, close, or change status.

Already have an account? Sign in to manage your watchlists.

Data sourced from ClinicalTrials.gov via Kisho's automated pipeline. Trials refreshed every 4 hours for monitored diseases.

Last sync: March 19, 2026 at 11:04 PM